{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:28:06Z","timestamp":1793190486125,"version":"4.5.0"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T00:00:00Z","timestamp":1589846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010950","name":"Science and Technology Department, Henan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010950","name":"Science and Technology Department, Henan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2020.00505","type":"journal-article","created":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T07:50:48Z","timestamp":1589961048000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Elevated Plasma Melatonin Levels Are Correlated With the Non-motor Symptoms in Parkinson\u2019s Disease: A Cross-Sectional Study"],"prefix":"10.3389","volume":"14","author":[{"given":"Linyi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenxiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1055\/s-0034-1384587","article-title":"A double-blind, placebo-controlled trial related to the effects of melatonin on oxidative stress and inflammatory parameters of obese women.","volume":"47","author":"Alamdari","year":"2014","journal-title":"Brain Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1080\/00140130500100967","article-title":"Effects of daytime ingestion of melatonin on short-term athletic performance.","volume":"48","author":"Atkinson","year":"2005","journal-title":"Ergonomics"},{"key":"B3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.brainres.2014.09.068","article-title":"Neuroprotective and antidepressant-like effects of melatonin in a rotenone-induced Parkinson\u2019s disease model in rats.","volume":"1593","author":"Bassani","year":"2014","journal-title":"J. Brain Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.sleep.2015.06.018","article-title":"Effect of melatonin on sleep disorders in a monkey model of Parkinson\u2019s disease.","volume":"16","author":"Belaid","year":"2015","journal-title":"Sleep Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1002\/mds.26592","article-title":"Hypothalamic volume loss is associated with reduced melatonin output in Parkinson\u2019s disease.","volume":"31","author":"Breen","year":"2016","journal-title":"Mov. Disord."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2014.65","article-title":"Sleep and circadian rhythm regulation in early Parkinson Disease.","volume":"71","author":"Breen","year":"2014","journal-title":"JAMA Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.brainres.2015.12.036","article-title":"Chronic low-dose melatonin treatment maintains nigrostriatal integrity in an intrastriatal rotenone model of Parkinson\u2019s disease.","volume":"1633","author":"Carriere","year":"2016","journal-title":"J Pineal Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/s0531-5565(96)00173-8","article-title":"Melatonin levels in Parkinson\u2019s disease: Drug therapy versus electrical stimulation of the internal globus pallidus.","volume":"32","author":"Catal\u00e1","year":"1997","journal-title":"Mov. Disord."},{"key":"B9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1001\/jamaneurol.2018.3758","article-title":"Neuropathology of circadian alterations in parkinson disease\u2014reply.","volume":"76","author":"De Pablo-Fern\u00e1ndez","year":"2019","journal-title":"JAMA Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/mds.25870","article-title":"Cognitive impairment and dementia in Parkinson\u2019s disease: practical issues and management.","volume":"29","author":"Emre","year":"2014","journal-title":"Mov. Disord."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2016.03.012","article-title":"Microbiota-Gut-Brain signalling in Parkinson\u2019s disease: implications for non-motor symptoms.","volume":"27","author":"Felice","year":"2016","journal-title":"Parkinson. Relat. Disord."},{"key":"B12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/bf02251135","article-title":"Circadian secretion pattern of melatonin in Parkinson\u2019s disease.","volume":"3","author":"Fertl","year":"1991","journal-title":"J. Neural Trans Parkinson Dis. Dement. Sect."},{"key":"B13","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/bf02257677","article-title":"Circadian secretion pattern of melatonin in de novo Parkinsonian patients: evidence for phase-shifting properties of l-dopa.","volume":"5","author":"Fertl","year":"1993","journal-title":"J. Neural Trans Parkinson Dis. Dement. Sect."},{"key":"B14","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1002\/mds.26865","article-title":"Alterations of the circadian system in Parkinson\u2019s disease patients.","volume":"32","author":"Fifel","year":"2017","journal-title":"Mov. Disord."},{"key":"B15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/s0167-4943(96)00754-6","article-title":"Improvement of sleep quality by controlled-release melatonin in benzodiazepine-treated elderly insomniacs.","volume":"24","author":"Garfinkel","year":"1997","journal-title":"Archiv. Gerontol. Geriatr."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1152\/physrev.00009.2009","article-title":"Physiology of circadian entrainment.","volume":"90","author":"Golombek","year":"2010","journal-title":"Physiol. Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s00415-010-5786-y","article-title":"Impact of psychiatric symptoms and sleep disorders on the quality of life of patients with Parkinson\u2019s disease.","volume":"258","author":"G\u00f3mez-Esteban","year":"2010","journal-title":"J. Neurol."},{"key":"B18","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease.","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"B19","doi-asserted-by":"crossref","DOI":"10.1016\/S0378-1119(97)00131-5","article-title":"Structure and organization of the gene encoding human dopamine transporter.","volume":"195","author":"Kawarai","year":"1997","journal-title":"Gene"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2017.00091","article-title":"Dopamine: a modulator of circadian rhythms in the central nervous system.","volume":"11","author":"Korshunov","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"B21","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2147\/CIA.S65625","article-title":"Add-on prolonged-release melatonin for cognitive function and sleep in mildto moderate Alzheimer\u2019s disease: a 6-month, randomized, placebo-controlled, multicenter trial.","volume":"9","author":"Laudon","year":"2014","journal-title":"Clin. Interv. Aging"},{"key":"B22","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/mp.2016.47","article-title":"Circadian rhythm dysfunction: a novel environmental risk factor for Parkinson\u2019s disease.","volume":"22","author":"Lauretti","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"B23","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.neulet.2009.12.008","article-title":"Melatonin is released in the third ventricle in humans. A study in movement disorders.","volume":"469","author":"Leston","year":"2009","journal-title":"Brain Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.brainres.2013.12.021","article-title":"Serum melatonin is an alternative index of Parkinson\u2019s disease severity.","volume":"1547","author":"Lin","year":"2014","journal-title":"Brain Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.lfs.2013.01.007","article-title":"Increased melatonin may play dual roles in the striata of a 6-hydroxydopamine model of Parkinson\u2019s disease.","volume":"92","author":"Lin","year":"2013","journal-title":"Life Sci."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12490","article-title":"Melatonin and cardioprotection against ischaemia\/reperfusion injury: what\u2019s new?","volume":"65","author":"Lochner","year":"2018","journal-title":"J. Pineal Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/9286458","article-title":"Melatonin ameliorates the progression of atherosclerosis via mitophagy activation and NLRP3 inflammasome inhibition.","volume":"2018","author":"Ma","year":"2018","journal-title":"Oxidat. Med. Cell. Long."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-079x.2012.01014.x","article-title":"A review of the molecular aspects of melatonin\u2019s anti-inflammatory actions: recent insights and new perspectives.","volume":"54","author":"Mauriz","year":"2013","journal-title":"J. Pineal Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"9377","DOI":"10.1073\/pnas.0503584102","article-title":"Regulation of dopaminergic transmission and cocaine reward by the Clock gene.","volume":"102","author":"Mcclung","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B30","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.neuroscience.2014.07.081","article-title":"Circadian insights into dopamine mechanisms.","volume":"282","author":"Mendoza","year":"2014","journal-title":"Neuroscience"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1126\/science.aah4968","article-title":"Mechanisms linking circadian clocks, sleep, and neurodegeneration.","volume":"354","author":"Musiek","year":"2016","journal-title":"Physiol. Rev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/jpi.12212","article-title":"Melatonin enhances L-DOPA therapeutic effects, helps to reduce its dose and protects dopaminergic neurons in MPTP-induced parkinsonism in mice.","volume":"58","author":"Naskar","year":"2015","journal-title":"J. Pineal Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1016\/j.neurobiolaging.2011.10.015","article-title":"Effect of melatonin on \u03b1-synuclein self-assembly and cytotoxicity.","volume":"33","author":"Onoa","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1111\/j.1471-4159.1980.tb11272.x","article-title":"Transport of albumin-bound melatonin through the blood-brain barrier.","volume":"34","author":"Pardridge","year":"1980","journal-title":"J. Neurochem."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease.","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"B36","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/j.1749-6632.1997.tb48415.x","article-title":"Prophylactic actions of melatonin in oxidative neurotoxicity.","volume":"825","author":"Reiter","year":"2006","journal-title":"Mov. Disord."},{"key":"B37","first-page":"e1145","article-title":"Bright light therapy for depression in Parkinson disease: A randomized controlled trial.","volume":"92","author":"Rutten","year":"2019","journal-title":"Mov. Disord."},{"key":"B38","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/jpi.12054","article-title":"Melatonin protects against ischemic heart failure in rats.","volume":"55","author":"\u015eehirli","year":"2013","journal-title":"Pineal Res."},{"key":"B39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00018-017-2549-2","article-title":"The implication of neuronimmunoendocrine (NIE) modulatory network in the pathophysiologic process of Parkinson\u2019s disease.","volume":"74","author":"Shen","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"B40","doi-asserted-by":"crossref","DOI":"10.1152\/ajpgi.00074.2013","article-title":"Melatonin inhibits alcohol-induced increases in duodenal mucosal permeability in rats in vivo.","volume":"305","author":"Sommansson","year":"2013","journal-title":"Am. J. Physiol. Gastrointest Liver Physiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease.","volume":"25","author":"Tomlinson","year":"2010","journal-title":"Mov. Disord."},{"key":"B42","doi-asserted-by":"crossref","DOI":"10.1007\/s11910-016-0664-3","article-title":"Melatonin for sleep disorders in patients with neurodegenerative diseases.","volume":"16","author":"Trotti","year":"2016","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"B43","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.parkreldis.2013.03.014","article-title":"\u201cSleep benefit\u201d in Parkinson\u2019s disease: a systematic review.","volume":"19","author":"Van Gilst","year":"2013","journal-title":"Parkinsonism. Relat. Disord."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2013.6239","article-title":"Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson Disease.","volume":"71","author":"Videnovic","year":"2014","journal-title":"JAMA Neurol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.expneurol.2013.01.014","article-title":"Circadian dysfunction may be a key component of the non-motor symptoms of Parkinson\u2019s disease: Insights from a transgenic mouse model.","volume":"243","author":"Willison","year":"2013","journal-title":"Exp. Neurol."},{"key":"B46","first-page":"66","article-title":"Treatment strategies for Parkinson\u2019s disease.","volume":"26","author":"Yuan","year":"2010","journal-title":"Brain Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1081\/cbi-120015958","article-title":"Aging and the circadian rhythm of melatonin: a cross-sectional study of chinese subjects 30\u2013110 yr of age.","volume":"19","author":"Zhao","year":"2009","journal-title":"Chronobiol. Int."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2020.00505\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T07:50:54Z","timestamp":1589961054000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2020.00505\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,19]]},"references-count":47,"alternative-id":["10.3389\/fnins.2020.00505"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2020.00505","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,19]]},"article-number":"505"}}